SGLT2 Inhibition in Hemodialysis

NCT05179668 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Kidney Failure
Hemodialysis
Diabetes Mellitus, Type 2
Chronic Kidney Disease
Left Ventricular Hypertrophy

Interventions

DRUG: Dapagliflozin 10 MG
DRUG: Placebo

Sponsor

Medical University of Vienna